Tehran University of Medical Sciences: Sclerosis trials

The registry lists 10 Sclerosis studies with Tehran University of Medical Sciences as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 2Phase 3 2Phase 4 5No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis PatientsCompletedNCT01225289Phase 4Results posted
• Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple SclerosisCompletedNCT06360861Phase 1
• Investigating the Effects of Hydroxyvitamin D3 on Multiple SclerosisStatus unknownNCT05340985Phase 4
• The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy SubjectsCompletedNCT02463318Not applicable
• The Effect of GCSF in the Treatment of ALS PatientsCompletedNCT01825551Phase 2/3
• Impact of Vitamin A on RAR Gene Expression in Multiple SclerosisStatus unknownNCT01705457Phase 4
• Impact of Vitamin A on Multiple Sclerosis (MS)Status unknownNCT01417273Phase 4
• Impact of Vitamin A on Gene Expression, in Multiple Sclerosis PatientStatus unknownNCT01407211Phase 4
• Melatonin in Relapsing-Remitting Multiple Sclerosis PatientsCompletedNCT01279876Phase 2
• Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to PlaceboCompletedNCT00668343Phase 3